Lataa...
Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
SIMPLE SUMMARY: Doxorubicin (Dox) is a chemotherapeutic agent usually employed for the treatment of breast cancer. However, its use is limited because of the toxicities associated, and hence a proper delivery vehicle is necessary. In this sense, albumin-based nanocarriers are in the limelight for th...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235501/ https://ncbi.nlm.nih.gov/pubmed/34208533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123011 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|